Jefferies Group's NVAX Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 0 shares of Novavax, Inc. (NVAX) worth $0, representing 0.00% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in NVAX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 673,120 shares. Largest reduction occurred in Q2 2026, reducing 673,120 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Novavax (NVAX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novavax (NVAX) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -673,120 | Sold Out | 0 | $0.00 |
| Q1 2026 | +673,120 | New Buy | 673,120 | $8.14 |
| Q1 2025 | -56,611 | Sold Out | 0 | $0.00 |
| Q4 2024 | -1,700 | Reduce 2.92% | 56,611 | $8.04 |
| Q3 2024 | +6,073 | Add 11.63% | 58,311 | $12.63 |
| Q2 2024 | -4,373 | Reduce 7.72% | 52,238 | $12.66 |
| Q4 2023 | +56,611 | New Buy | 56,611 | $4.80 |
| Q2 2023 | -15,000 | Sold Out | 0 | $0.00 |
| Q1 2023 | -11,791 | Reduce 44.01% | 15,000 | $6.93 |
| Q4 2022 | +26,791 | New Buy | 26,791 | $10.28 |
Jefferies Group's Novavax Investment FAQs
Jefferies Group first purchased Novavax, Inc. (NVAX) in Q4 2022, acquiring 26,791 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Novavax, Inc. (NVAX) for 11 quarters since Q4 2022.
Jefferies Group's largest addition to Novavax, Inc. (NVAX) was in Q1 2026, adding 673,120 shares worth $5.48 M.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 0 shares of Novavax, Inc. (NVAX), valued at approximately $0.
As of the Q2 2026 filing, Novavax, Inc. (NVAX) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Novavax, Inc. (NVAX) was 673,120 shares, as reported at the end of Q1 2026.